https://t.co/vxM9alWfg6

Mesenchymal stromal cells from JAK2V617F myeloproliferative neoplasms support healthy and malignant hematopoiesis in a humanized scaffold model in vivo https://t.co/IJsEUBTe5n #MPNsm #MDSsm #microenvironment @Hemasphere_EHA @KordastiL @harrisoncn1 @TheCrick @MPN_Hub @MDS_Hub

Our new paper out! ✨ We built a humanized mouse model of JAK2-mutated MPN by embedding patient MSCs & progenitors in a gelatin scaffold to recreate bone marrow. It preserves disease genetics and enables research on immune response & immunotherapies. 🔗 Link in first comment

Check out our paper looking at QRISK3 score as a predictor of thrombotic risk in MPN patients . Great collaborative work led by Patrick Harrington and Andrea Duminuco @ADuminuco #mpn https://t.co/H9ps0VGdjW

#EHA2025 #EHA25 || 👉Great to meet up with all-stars 🌍 myeloid malignancy research @doctorpemm @Ramikomrokji Dr. Santini @KordastiL @sanamloghavi ||

#EHA2025 #EHA25 ||| Wonderful catch-up with @doctorpemm @KordastiL & @sanamloghavi | #MPNSM #inflammation #hemepath

Excited to share our @nih_nhlbi work led by Alice Wu in collaboration with @KingsCollegeLon published in @NatureComms using scRNAseq and CyTOF to explore pathophysiology of immune #aplasticanemia pre and post IST. https://t.co/xswXd8cIKy @NealSYoung1 @bhavishap29 @KordastiL

Dear friends, This account will be deactivated and deleted in about a month. Join us on Bluesky Social for updates and discussions. See you there! 🌿🔬 https://t.co/QthLhn1wkF

Friends, I am at a loss of words for how devastating it would be to lose the entire intramural #NIH program. Some of the biggest medical and scientific breakthroughs have come from scientists in the NIH Intramural program. #SaveTheNIH https://t.co/UlkCDfHD7f

Immune-monitoring of myelodysplastic neoplasms: Recommendations from the #i4MDS consortium https://t.co/YedhhlvgCM @Hemasphere_EHA @KordastiL #MDSsm @aamdsif @ic_MDS @MDS_Hub @MDSAlliance @MDSFoundation

In past 2 days, we had our annual #i4MDS meeting in The Hague. Great discussions with colleagues about the role of the immune system in MDS and novel findings. Three years ago, when we founded this group, I never expected this level of progress and collaboration. Truly delighted.

It was great to have @Dr_AmerZeidan in our annual #i4MDS meeting at the Hague (virtually). He gave an excellent talk on the future of ICI in #MDS. Many thanks Amer for the great talk!

United by Unique #Cancer

I spent the past three days in Bergen university, Norway, giving a lecture for the Haemato-Oncology group and conducting a research methodology workshop for medical students. I thoroughly enjoyed the scientific discussions and exchanges with the students and colleagues.

Huge congratulations to Antonio Curti and his team for this remarkable work. The research proposes EV-based liquid biopsy as a noninvasive tool for metabolic stratification, and targeting the glutathione-GPX4 axis and metabolic dependencies in #AML. https://t.co/h7hjo08Xa6

How can T cells revolutionise cancer treatment? Discover how in the latest episode of the Hema Now podcast, featuring Dr @SKordasti, @KordastiL, @KingsCollegeLon: https://t.co/J7lZX1fzr8

In this podcast, hosted by Dr. Jonathan Sackier and published today in the EMJ, I discussed various advancements in the field of cancer immunotherapy. At the beginning, I also talked a little about myself and how I became interested in this field. https://t.co/yff8DZ9Xum

Happy New Year! Wishing you all a wonderful year ahead, filled with joy and happiness 😊🎉

And the last clinic before Christmas! Wishing you all a very happy holiday season!

Excellent talk from colleague Zhijie Wu who presented our lab’s data on T-cell clonality and dynamics after IST in #SAA. #ASH24 @ASH_hematology @NealSYoung1 @KordastiL @bhavishap29 @nih_nhlbi